FTSE All-Share
5.329,48
PKT
+28,09
PKT
+0,53
%
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.07.12 | Imperial Brands neutral | Nomura | |
| 04.07.12 | Barclays outperform | Credit Suisse Group | |
| 04.07.12 | Burberry buy | Nomura | |
| 04.07.12 | Rio Tinto buy | Deutsche Bank AG | |
| 04.07.12 | Barclays kaufen | Independent Research GmbH | |
| 04.07.12 | Smith Nephew neutral | UBS AG | |
| 04.07.12 | Persimmon buy | UBS AG | |
| 04.07.12 | Lloyds Banking Group buy | UBS AG | |
| 04.07.12 | HSBC buy | Société Générale Group S.A. (SG) | |
| 04.07.12 | Shell (ex Royal Dutch Shell) buy | Deutsche Bank AG | |
| 04.07.12 | Imperial Brands buy | Société Générale Group S.A. (SG) | |
| 04.07.12 | Diageo hold | ING | |
| 04.07.12 | BP buy | Deutsche Bank AG | |
| 04.07.12 | Vodafone Group buy | Citigroup Corp. | |
| 04.07.12 | Anglo American buy | Deutsche Bank AG | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | Barclays buy | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | Antofagasta buy | Nomura | |
| 03.07.12 | Anglo American neutral | Nomura | |
| 03.07.12 | Standard Chartered halten | Independent Research GmbH | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 03.07.12 | GSK buy | Citigroup Corp. | |
| 03.07.12 | Unilever hold | ING | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 03.07.12 | GSK neutral | J.P. Morgan Cazenove | |
| 03.07.12 | Imperial Brands underperform | Exane-BNP Paribas SA | |
| 03.07.12 | BAT overweight | J.P. Morgan Cazenove | |
| 03.07.12 | Vodafone Group overweight | Morgan Stanley | |
| 03.07.12 | Unilever halten | Norddeutsche Landesbank (Nord/LB) | |
| 03.07.12 | GSK buy | Société Générale Group S.A. (SG) | |
| 03.07.12 | Barclays hold | Deutsche Bank AG | |
| 02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 02.07.12 | Barclays buy | UBS AG | |
| 02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 02.07.12 | Mobico Group neutral | J.P. Morgan Cazenove | |
| 02.07.12 | Barclays overweight | J.P. Morgan Cazenove | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 02.07.12 | Unilever buy | ING | |
| 02.07.12 | Barclays buy | Deutsche Bank AG |